Report Scope & Overview
Scleral Lens Market size was valued at USD 276.15 Million in 2022 and is expected to reach USD 868.54 Million By 2030 and grow at a CAGR of 15.4% over the forecast period of 2023-2030.
The global market for scleral lenses, which are specialised contact lenses created to cover the entire corneal surface and rest on the sclera (white area of the eye), is referred to as the Scleral Lens Market. Scleral lenses are often used to treat a number of eye problems, such as keratoconus, uneven corneas, and severe dry eye syndrome. They are bigger than conventional contact lenses. Due to a number of variables, the scleral lens industry has been rapidly expanding in recent years. First of all, scleral lenses are now a feasible choice for a wider group of patients thanks to developments in technology and materials that have improved their comfort and fit. The growing demand for scleral lenses is also influenced by the ageing population and the rising frequency of eye problems.
Scleral lenses come in a variety of sizes and shapes, including mini-scleral lenses, large-diameter lenses, and Toric scleral lenses. These lenses are often produced by specialised contact lens firms and are typically recommended by eye care specialists like optometrists and ophthalmologists. The market for scleral lenses is impacted by a number of variables, including the availability of cutting-edge lens designs, improvements in manufacturing processes, regulatory frameworks, and reimbursement policies. With multiple significant competitors operating on a worldwide scale, it is a dynamic and competitive market. Scleral lenses are used to treat vision problems like presbyopia, hyperopia, astigmatism, uneven corneas, ocular surface disease, and myopia. Over the course of the projection period, it is anticipated that this disease's rising prevalence will drive the scleral lens market. According to the World Health Organisation, East Asian nations, including Singapore, South Korea, and Japan, have the highest frequency of myopia. According to a 2019 article from the National Centre for Biotechnology Information, by the year 2050, myopia and high myopia are both predicted to impact 4,950 million and 926 million individuals worldwide, respectively.
The need for scleral lenses has been pushed by the increasing frequency of eye disorders such as keratoconus, uneven corneas, and severe dry eye syndrome.
Blindness and eye conditions are becoming more prevalent.
In the upcoming years, the prevalence of various eye conditions such as myopia, astigmatism, and presbyopia is expected to increase, driving demand for scleral contact lenses.
Scleral lenses have a higher price tag than conventional contact lenses because of their customised, specialised design and production methods.
Scleral lenses are used when other contact lenses are ineffective.
Patients who are unable to locate the proper contact lenses to treat their visual problems can benefit from scleral lenses. Scleral lenses are preferable to gas-permeable lenses in terms of comfort, visual clarity, and stability. A scleral lens with a larger overall diameter is frequently beneficial for patients with ocular surface illnesses; however, this lens eventually needs advanced toric peripheral systems to align with the sclera. Scleral lenses are frequently the only practical solution in situations involving corneal irregularity or extreme sensitivity. The scleral lens market is being driven by these advantages.
Scleral lens design, comfort, and optical results may all be improved with ongoing technological and material breakthroughs.
Manufacturers can create a Scleral market.
Manufacturers will be able to create scleral lenses, such as bifocal scleral lenses, which are useful for treating a variety of diseases, including the correction of presbyopia, thanks to advancements in R8D lens design.
Despite rising awareness, scleral lenses continue to be poorly understood by both patients and certain eye care providers.
Optometrists and ophthalmologists need specialised training to prescribe these lenses.
The demand and supply for scleral lenses are segmented and examined for each distribution channel, including eye clinics, hospitals, and others. Of these, the segment for eye clinics is anticipated to expand significantly over the projection period.
Impact of Russia and Ukraine-War
Russian military troops began a military operation in Ukraine in February 2022, and it is expected that there will be ongoing violence and unrest in the area. The length, impact, and outcome of this ongoing military conflict are highly unpredictable and could cause significant market and other disruptions. These include significant volatility in commodity prices and the supply of energy resources, instability in financial markets, interruptions in supply chains, political and social unrest, Changes in consumer or buyer tastes, trade disputes or trade obstacles, as well as an uptick in cyberattacks and espionage.
Significant sanctions against Russia, Belarus, the Crimea Region of Ukraine, the so-called Donetsk People's Republic, and the so-called Luhansk People's Republic have been implemented as a result of the war by the United States, the European Union, the United Kingdom, Canada, Switzerland, Japan, and other nations. These sanctions include, among other things, blocking sanctions against some of the largest state-owned and private Russian financial institutions (and their subsequent removal from the Society for Worldwide). According to the Ministry of Internal Affairs and Communications, the average retail price in East Asia for a package of 90 soft contact lenses was $77 in February, an increase of 10.5% from five years earlier. An industry source reported that Johnson & Johnson and other contact lens manufacturers recently increased pricing, an uncommon action in a market known for severe price competitiveness. One explanation for the rise is higher production costs. In addition to increased energy costs, labour expenses have also risen as a result of a lack of workers.
Impact of Ongoing Recession
The financial state of company clients, suppliers, and other business partners may also suffer as a result of the persistently unstable economic and financial market conditions. Customers may buy fewer of our items when their financial situations are bad, and we might not be able to recover accounts receivable, both of which might materially harm our company's operations or financial results. Our international business has suffered impacted by regional economic factors, such as inflation, rising labour costs, the recession, and currency exchange rate fluctuations, which negatively impacted our expenses to produce and deliver our goods and services as well as the money we made from the sale of such goods and services.
The company is dedicated to ongoing innovation. The value of products to our installed customer base, which consists of Global 10,000 enterprises (G10K), SMBs, and consumers, increases as a result of our efforts in R&D. According to estimated total revenues, the G10K includes the largest governments and businesses in the world. organisations Greater distribution and cross-selling potential result from more valuable items when combined with our well-established worldwide partner programme, which helps us further achieve organic growth. The company have spent a total of $1.22 billion, or 12.4% of total sales, on research and development during the last three fiscal years. The company aim to allocate 13% to 15% of revenues per year for R&D expenses.
Surface Ocular Disease
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of the Middle East & Africa
Rest of Latin America
North America: On the global market for scleral lenses, North America is anticipated to account for the lion's share. Due to the increasing prevalence of eye disorders and injuries that are primarily driving the expansion, the United States is one of the most important countries in the scleral lens market. For instance, the National Eye Institute estimates that 13 million Americans will have impaired eyesight by 2023. By 2030, it is anticipated that there will be another increase in the number, bringing it to over 50 million. In addition, the Centres for Disease Control and Prevention reported that in 2020, there would be 55 million people in the United States who wore scleral lenses and who were 18 or older, making up around 22.3% of the adult population.
Asia-Pacific: Asia-Pacific is the region that dominates the global semiconductor market. 92% of vision loss is avoidable, and 63% of the world's visually impaired people reside in this area. For the approximately 511 million people who experience refractive vision issues, scleral lenses are useful. For a large number of people with ocular surface diseases, scleral lenses may be helpful. The growth in scleral lens awareness is due to Asia-Pacific accounting for the majority of the global scleral lens market.
The major key players are Art Optical Contact Lens Inc, (VisionaryOptic) Euclid Systems, Bausch & Lomb, Cooper Vision, Acculens, Solotica, ABB Optical Group, EssilorLuxottica, Optact International Ltd., Valley Contax Inc. and others.
Euclid Systems-Company Financial Analysis
CooperVision: For its Onefit MED and Onefit MED+ scleral contact lenses, CooperVision Specialty EyeCare released Optimised Pupil Optics (OPO) to eye care professionals (ECPs) in the United States and Canada in 2021.
Bausch Health Companies Inc: The New 28-Lens Zenlens Dx Set was introduced by Bausch Health Companies Inc. in 2021 in response to the rising demand for gas-permeable lenses to treat vision issues brought on by abnormalities in the cornea.
|Market Size in 2022||US$ 276.15 Mn|
|Market Size by 2030||US$ 868.54 Mn|
|CAGR||CAGR of 15.4 % From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Type (Mini, and Large)
• By Indication (Surface Ocular Disease, Corneal Irregularity, Refractive Error, Others)
• By End-user (Hospital, Eye clinic, and other)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Art Optical Contact Lens Inc, (VisionaryOptic) Euclid Systems, Bausch & Lomb, Cooper Vision, Acculens, Solotica, ABB Optical Group, EssilorLuxottica, Optact International Ltd., Valley Contax Inc. and others|
|Key Drivers||• The need for scleral lenses has been pushed by the increasing frequency of eye disorders such as keratoconus, uneven corneas, and severe dry eye syndrome.
• Blindness and eye conditions are becoming more prevalent.
|Market Opportunities||• Scleral lens design, comfort, and optical results may all be improved with ongoing technological and material breakthroughs.
• Manufacturers can create a Scleral market.
Ans: The Scleral Lens Market size was evaluted USD 276.15 Million in 2022.
Ans: The Scleral Lens Market is growing at 15.4% Over the Forecast Period 2023-2030.
Ans: The Scleral Lens Market will hit USD 868.54 Billion by 2030.
Ans: Scleral lenses are reusable and long-lasting.
Ans: The major key players are Art Optical Contact Lens Inc, (VisionaryOptic) Euclid Systems, Bausch & Lomb, Cooper Vision, Acculens, Solotica, ABB Optical Group, EssilorLuxottica, Optact International Ltd., Valley Contax Inc. and others.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 Impact of the Ukraine-Russia War
4.2 Impact of Ongoing Recession
4.2.2 Impact on major economies
22.214.171.124 United Kingdom
126.96.36.199 South Korea
188.8.131.52 Rest of the World
4.3 Supply Demand Gap Analysis
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Scleral Lens Market Segmentation, by Type
9. Scleral Lens Market Segmentation, by Indication
9.1 Surface Ocular Disease
9.2 Corneal Irregularity
9.3 Refractive Error
10. Scleral Lens Market Segmentation, by End-User
10.2 Eye clinic
11. Regional Analysis
11.2 North America
11.2.1 North America Scleral Lens Market by Country
11.2.2North America Scleral Lens Market by Type
11.2.3 North America Scleral Lens Market by Indication
11.2.4 North America Scleral Lens Market by End-User
184.108.40.206 USA Scleral Lens Market by Type
220.127.116.11 USA Scleral Lens Market by Indication
18.104.22.168 USA Scleral Lens Market by End-User
22.214.171.124 Canada Scleral Lens Market by Type
126.96.36.199 Canada Scleral Lens Market by Indication
188.8.131.52 Canada Scleral Lens Market by End-User
184.108.40.206 Mexico Scleral Lens Market by Type
220.127.116.11 Mexico Scleral Lens Market by Indication
18.104.22.168 Mexico Scleral Lens Market by End-User
11.8.1 Europe Scleral Lens Market by Country
11.8.2 Europe Scleral Lens Market by Type
11.8.3 Europe Scleral Lens Market by Indication
11.8.4 Europe Scleral Lens Market by End-User
22.214.171.124 Germany Scleral Lens Market by Type
126.96.36.199 Germany Scleral Lens Market by Indication
188.8.131.52 Germany Scleral Lens Market by End-User
184.108.40.206 UK Scleral Lens Market by Type
220.127.116.11 UK Scleral Lens Market by Indication
18.104.22.168 UK Scleral Lens Market by End-User
22.214.171.124 France Scleral Lens Market by Type
126.96.36.199 France Scleral Lens Market by Indication
188.8.131.52 France Scleral Lens Market by End-User
184.108.40.206 Italy Scleral Lens Market by Type
220.127.116.11 Italy Scleral Lens Market by Indication
18.104.22.168 Italy Scleral Lens Market by End-User
22.214.171.124 Spain Scleral Lens Market by Type
126.96.36.199 Spain Scleral Lens Market by Indication
188.8.131.52 Spain Scleral Lens Market by End-User
11.3.11 The Netherlands
184.108.40.206 Netherlands Scleral Lens Market by Type
220.127.116.11 Netherlands Scleral Lens Market by Indication
18.104.22.168 Netherlands Scleral Lens Market by End-User
11.3.12 Rest of Europe
22.214.171.124 Rest of Europe Scleral Lens Market by Type
126.96.36.199 Rest of Europe Scleral Lens Market by Indication
188.8.131.52 Rest of Europe Scleral Lens Market by End-User
11.4.1 Asia Pacific Scleral Lens Market by Country
11.4.2 Asia Pacific Scleral Lens Market by Type
11.4.3 Asia Pacific Scleral Lens Market by Indication
11.4.4 Asia Pacific Scleral Lens Market by End-User
184.108.40.206 Japan Scleral Lens Market by Type
220.127.116.11 Japan Scleral Lens Market by Indication
18.104.22.168 Japan Scleral Lens Market by End-User
11.4.7 South Korea
22.214.171.124 South Korea Scleral Lens Market by Type
126.96.36.199 South Korea Scleral Lens Market by Indication
188.8.131.52 South Korea Scleral Lens Market by End-User
184.108.40.206 China Scleral Lens Market by Type
220.127.116.11 China Scleral Lens Market by Indication
18.104.22.168 China Scleral Lens Market by End-User
22.214.171.124 India Scleral Lens Market by Type
126.96.36.199 India Scleral Lens Market by Indication
188.8.131.52 India Scleral Lens Market by End-User
184.108.40.206 Australia Scleral Lens Market by Type
220.127.116.11 Australia Scleral Lens Market by Indication
18.104.22.168 Australia Scleral Lens Market by End-User
11.4.11 Rest of Asia-Pacific
22.214.171.124 APAC Scleral Lens Market by Type
126.96.36.199 APAC Scleral Lens Market by Indication
188.8.131.52 APAC Scleral Lens Market by End-User
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Scleral Lens Market by Country
11.5.2 The Middle East & Africa Scleral Lens Market by Type
11.5.3 The Middle East & Africa Scleral Lens Market by Indication
11.5.4 The Middle East & Africa Scleral Lens Market by End-User
184.108.40.206 Israel Scleral Lens Market by Type
220.127.116.11 Israel Scleral Lens Market by End-User
18.104.22.168 Israel Scleral Lens Market by Indication
22.214.171.124 UAE Scleral Lens Market by Type
126.96.36.199 UAE Scleral Lens Market by Indication
188.8.131.52 UAE Scleral Lens Market by End-User
11.5.8 South Africa
184.108.40.206 South Africa Scleral Lens Market by Type
220.127.116.11 South Africa Scleral Lens Market by Indication
18.104.22.168 South Africa Scleral Lens Market by End-User
11.5.9 Rest of Middle East & Africa
22.214.171.124 Rest of Middle East & Asia Scleral Lens Market by Type
126.96.36.199 Rest of Middle East & Asia Scleral Lens Market by Indication
188.8.131.52 Rest of Middle East & Asia Scleral Lens Market by End User
11.6 Latin America
11.6.1 Latin America Scleral Lens Market by Country
11.6.2 Latin America Scleral Lens Market by Type
11.6.3 Latin America Scleral Lens Market by Indication
11.6.4 Latin America Scleral Lens Market by End-User
184.108.40.206 Brazil Scleral Lens Market by Type
220.127.116.11 Brazil Scleral Lens Market by Indication
18.104.22.168 Brazil Scleral Lens Market by End-User
22.214.171.124 Argentina Scleral Lens Market by Type
126.96.36.199 Argentina Scleral Lens Market by Indication
188.8.131.52 Argentina Scleral Lens Market by End-User
11.6.8 Rest of Latin America
184.108.40.206 Rest of Latin America Scleral Lens Market by Type
220.127.116.11 Rest of Latin America Scleral Lens Market by Indication
18.104.22.168 Rest of Latin America Scleral Lens Market by End-User
12. Company profile
12.1 Art Optical Contact Lens, Inc
12.1.1 Market Overview
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 (VisionaryOptic) Euclid Systems
12.2.1 Market Overview
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Bausch & Lomb
12.3.1 Market Overview
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Cooper Vision
12.4.1 Market Overview
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5.1 Market Overview
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6.1 Market Overview
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 ABB Optical Group
12.7.1 Market Overview
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Optact International Ltd.
12.9.1 Market Overview
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Valley Contax Inc
12.11.1 Market Overview
12.11.4 SWOT Analysis
12.11.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Types
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Clinical Risk Grouping Solutions Market Size was valued at USD 640 million in 2022, and is expected to reach USD 1890 million by 2030, and grow at a CAGR of 14.5% over the forecast period 2023-2030.
The Drug Eluting Stent Market size was estimated USD 2897.6 million in 2022 and is expected to reach USD 4795.51million by 2030 at a CAGR of 6.5% during the forecast period of 2023-2030.
The Preeclampsia Diagnostics Market size was valued at USD 1.07 Billion in 2022 and is expected to reach USD 1.24 Billion By 2030 and grow at a CAGR of 2.4% over the forecast period of 2023-2030.
The Augmented and Virtual Reality Contact Lenses Market size was valued at USD 37.2 billion in 2022 and is expected to grow to USD 226.02 billion by 2030 and grow at a CAGR of 25.3 % over the forecast period of 2023-2030.
The Healthcare BPO Market Size was valued at USD 327.86 billion in 2022 and is expected to reach USD 692.64 billion by 2030 and grow at a CAGR of 9.8% over the forecast period 2023-2030.
The Postpartum Products Market size was estimated USD 2.38 billion in 2022 and is expected to reach USD 3.97 billion by 2030 at a CAGR of 6.6% during the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone